Table 1 Baseline characteristics of the patients included the study
From: Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia
Characteristic | Â | Value |
|---|---|---|
Age (year) |  | 62 ± 10 |
Sex | Female | 5 (36%) |
Levels of vascular risk | Coronary artery disease | 11 (79%) |
| Â | Diabetes mellitus | 6 (43%) |
| Â | Peripheral artery disease | 1 (7%) |
| Â | Stroke | 3 (21%) |
| Â | Hypertension | 10 (71%) |
Statins | Strong statin | 9 (64%) |
Co-medication | Renin-angiotensin system inhibitors | 14 (100%) |
|  | β-blockers | 11 (79%) |
| Â | Aspirin | 10 (71%) |
| Â | Antidiabetic agents | 4 (31%) |